ALDEYRA THERAPEUTICS, INC. (ALDX) Capital expenditures 2016–2023
ALDEYRA THERAPEUTICS, INC. (ALDX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2023 · since FY2016: $11,810 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $0 | -100.0% |
| FY2022 | $16,317 | +109.0% |
| FY2021 | $7,806 | — |
| FY2019 | $9,529 | -96.4% |
| FY2018 | $262,966 | +962.1% |
| FY2017 | $24,759 | +109.6% |
| FY2016 | $11,810 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice